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forming and coagulation proteins, and (vi) immunoassays for complement compo-
nents. Each of the six sections contains four papers, which are well-organized and
comprehensive, having an outline of their contents on the title page and often
including.discussions of materials, methods, apparatus, and potential limitations in
addition to the principles behind the technique in question. Throughout the volume,
numerous figures and tables illustrate and reinforce the text; the articles are well-
referenced and some even include impressive appendices which describe the experi-
mental procedures involved.
Certain papers in the volume are excellent and quite timely. Quaranta et al.
have written an article on the preparation and characterization of monoclonal
antibodies to human melanoma associated antigens and to human histocompatibility
antigens; two appendices conclude the paper and present the technical details,
procedures, and materials employed. Other noteworthy presentations include im-
proved techniques in ELISA for viruses and viral antibodies by Johnson and
Nakamura, new developments in the activation of the complement alternative
pathway by Schreiber and Muller-Eberhard, rosette assays for human lymphocyte
membrane receptors bySpiegelbergand Gonzalez-Molina, lymphomicrocytotoxicity
tests by Ferrone et al., and many more fine articles covering highlypertinent areas of
interest to biochemists, immunologists, pathologists, and others. Because of the
outstanding manner in which most contributors have presented and explained their
areas ofexpertise, as well as provided the methodological details so necessary forthe
success of a researcher new to a particular system, this volume is likely to prove
instrumental to all those interested or involved in this rapidly evolving field.
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Some have suggested that proceedings of scientific meetings should not be
published separately, but rather be subject to the usual process of peer review. The
present volume represents a good argument for such publication en bloc.
Enzyme Therapy in Genetic Diseases: 2 is a summary of the second international
symposium on this topic, held in March 1979. The volume, edited by conference
chairman Robert Desnick, is extremely well organized and arranged. The book is
divided into six sections: (1) Enzyme Availability: Purification/Characterization; (2)
Enzyme Recognition and Modification; (3) Animal Model Studies: Enzyme Entrap-
ment, Neural Delivery, and Transplantation; (4) Enzyme Manipulation: Mechanisms
and Therapeutic Trials; (5) Human Trials: Direct Enzyme Replacement; and (6)
Human Trials: Cell and Organ Transplantation/Other Therapeutic Approaches;
each section is preceded by a broad overview and followed by a summary and
discussion.
Since the molecular nature ofinherited diseases was first theorized in the early part
of this century, hundreds of such conditions have been described. Therapy for these
diseases, however, has been quite limited. The first and most obvious approach is to
replace the defective enzyme, but this method is fraught with difficulties. First, the
proteins must be isolated and purified in sufficient quantities. Next they must be
administered in such a way that they reach the affected areas ofthe body(oftenquite
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compartments without eliciting an immune response. Finally, such treatment must be
feasible from the patient's perspective; a bonus would be the ability to reverse damage
that had previously occurred.
Reports in this volume address each ofthese constraints, attempting to transfer the
most recent advances in cell biology to clinical medicine. As one example, the
problem of targeting the enzymes to their required sites includes such approaches as
the use of liposomes and erythrocyte ghosts for packaging, carbohydrate modifica-
tion to address enzymes to specific cellular receptors, and alterations in the recipient's
blood-brain barrier and immune system to facilitate delivery.
Particularly encouraging are reports of cellular transplants, notablyfibroblasts, to
produce continuous supplies of the missing proteins, while also exhibiting some
physiologic feedback control. Repeated mention is made of the possible boon
provided by genetic engineering for the production of macro quantities of pure
enzymes, and perhaps even for the direct replacement of the defective genes. Several
therapeutic approaches not involving replacement of the deficient enzyme are
described as well. These include cofactor supplementation, dietary modifications,
hormone therapy, and plasmapheresis.
It should be pointed out that most of the clinical trials reported were of a
preliminary nature, often involving only a few cases; the results were frequently
negative or equivocal at best. As such, strictly speaking, this volume is of relatively
minor value to the clinician, aside from its inherent interest. However, as a guide to
the future course of therapy in this field, the book is quite comprehensive; more
important, as a source ofexceptionally creative approaches to bridgingtheforefront
of basic science and that of clinical medicine, this book's value extends well beyond
the therapy of genetic diseases. Participants in the symposium ranged from protein
chemists to transplant surgeons, and the influence of all of these workers gives this
volume its broad approach.
Returning to the question of publishing symposia as separate volumes, almost all
of the articles presented would be able to stand alone; yet arranged in this coherent
unit, they represent a creative, dynamic model of scientific collaboration.
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Conventional biochemical techniques have provided much of our present knowl-
edge about the enzymatic makeup of most tissues. With increasing technical
advances in tissue and cell fractionation, such studies have been used to examine
component cells and organelles. These analyses have offered a great deal of
information on the biological activities ofawide range ofmaterials, yet they have not
been able to contribute much to our understanding of biological and chemical
differences between cells in organized tissue structures.
One method employed to investigate biological activities in heterogeneous tissue is
microdissection, in which small pieces of tissue or individual cells are isolated and
then analyzed chemically. A second, more widely used approach, microscopic
histochemistry and cytochemistry, is the topic of the present symposium.
This discipline is concerned with developing visualization methods (including
optical absorbence, fluorescence, and electron scatter techniques) such that an object
can be observed and measured while revealing its relation to associated structures.